Related Experiment Video

Updated: May 2, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

1.0K

MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma

Chenggang Wang1, Ren Ren1, Haolin Hu1

  • 11 Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China ; 2 Shanghai Institute of Medical Imaging, Shanghai 200032, China ; 3 State Key Laboratory of Genetic Engineering and Institute of Developmental Biology and Molecular Medicine School of Life Sciences, Fudan University, Shanghai 200433, China ; 4 Liver Cancer Institude, Fudan University, Shanghai 200032, China ; 5 Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.

Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|March 22, 2014
PubMed

Insights

MicroRNA-182 (miR-182) is upregulated in hepatocellular carcinoma (HCC) and represses CEBPA, impacting the CEBPA/miR-122 pathway. This suggests miR-182 is an oncogene and potential biomarker for HCC.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are key regulators in hepatocellular carcinoma (HCC), acting as tumor suppressors or oncogenes.
  • MiR-122 is downregulated in HCC and functions as a tumor suppressor, with its regulation by CEBPA recently identified.
  • The regulatory relationship between CEBPA and miRNAs in HCC remains largely unexplored.

Purpose of the Study:

  • To investigate whether CEBPA is regulated by miRNAs in hepatocellular carcinoma (HCC).
  • To elucidate the role of miR-182 in the context of HCC and its impact on the CEBPA/miR-122 pathway.

Main Methods:

  • Utilized a rat model of hepatocellular carcinoma (HCC) to study microRNA expression.
  • Performed experiments in both rat and human cell systems to validate miRNA-target interactions.
  • Analyzed the regulatory effects of miR-182 on CEBPA expression and its downstream consequences.

Main Results:

  • miR-182 was found to be significantly upregulated in the HCC model rat.
  • miR-182 was demonstrated to directly repress the expression of CEBPA in both rat and human contexts.
  • The findings revealed that miR-182 enhances the CEBPA/miR-122 pathway, influencing tumor cell proliferation.

Conclusions:

  • miR-182 acts as an oncogene in hepatocellular carcinoma (HCC).
  • miR-182 represents a potential diagnostic marker for HCC.
  • miR-182 could serve as a therapeutic target for HCC treatment.
Keywords:
Cebpahepatocellular carcinoma (HCC)miR-122miR-182oncogene

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K